Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Luke

Showing results (71-80 of 356) with videos related to

Pageof 36
Sort By:
Biochemistry|December 14, 2005
Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid diseaseR Luke Wiseman, Evan T Powers, Jeffery W Kelly
Pharmaceutical Research|October 1, 1987
Pharmacokinetics of pentoxifylline during concomitant theophylline administration to ratsM L Rocci, D R Luke, C L Saccar
Biochemistry|November 23, 2005
The pathway by which the tetrameric protein transthyretin dissociatesTed R Foss, R Luke Wiseman, Jeffery W Kelly
Renal Failure|January 1, 1989
Role of vascular decongestion in ischemic acute renal failure defined by postinsult administration of pentoxifyllineD R Luke, K L Berens, R R Verani
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1989
Cilastatin-insulin interaction in the ratG C Tompkins, L J Brunner, D R Luke
Antimicrobial Agents and Chemotherapy|November 1, 1996
Safety, toleration, and pharmacokinetics of intravenous azithromycinD R Luke, G Foulds, S F Cohen, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Inhibition of NF-κB Signaling by the Reactive Glycolytic Metabolite MethylglyoxalCaroline Stanton, Woojin Choi, R Luke Wiseman, et al.
Expert Review of Anticancer Therapy|August 13, 2025
CD70-targeted allogeneic CAR T-cell therapy for clear cell renal cell carcinomaR Luke Bradley, Edwin Paul, Sharda Singh, et al.
AIDS Care|March 25, 2016
Receipt of clinical and prevention services, clinical outcomes, and sexual risk behaviors among HIV-infected young adults in care in the United StatesLinda Beer, Christine L Mattson, R Luke Shouse, et al.
Journal of Pharmaceutical Sciences|March 10, 2010
Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD)David R Luke, Konrad Tomaszewski, Bharat Damle, et al.
Pageof 36

Showing results (71-80 of 356) with videos related to

Sort By:
Pageof 36
Biochemistry|December 14, 2005
Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid diseaseR Luke Wiseman, Evan T Powers, Jeffery W Kelly
Pharmaceutical Research|October 1, 1987
Pharmacokinetics of pentoxifylline during concomitant theophylline administration to ratsM L Rocci, D R Luke, C L Saccar
Biochemistry|November 23, 2005
The pathway by which the tetrameric protein transthyretin dissociatesTed R Foss, R Luke Wiseman, Jeffery W Kelly
Renal Failure|January 1, 1989
Role of vascular decongestion in ischemic acute renal failure defined by postinsult administration of pentoxifyllineD R Luke, K L Berens, R R Verani
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1989
Cilastatin-insulin interaction in the ratG C Tompkins, L J Brunner, D R Luke
Antimicrobial Agents and Chemotherapy|November 1, 1996
Safety, toleration, and pharmacokinetics of intravenous azithromycinD R Luke, G Foulds, S F Cohen, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Inhibition of NF-κB Signaling by the Reactive Glycolytic Metabolite MethylglyoxalCaroline Stanton, Woojin Choi, R Luke Wiseman, et al.
Expert Review of Anticancer Therapy|August 13, 2025
CD70-targeted allogeneic CAR T-cell therapy for clear cell renal cell carcinomaR Luke Bradley, Edwin Paul, Sharda Singh, et al.
AIDS Care|March 25, 2016
Receipt of clinical and prevention services, clinical outcomes, and sexual risk behaviors among HIV-infected young adults in care in the United StatesLinda Beer, Christine L Mattson, R Luke Shouse, et al.
Journal of Pharmaceutical Sciences|March 10, 2010
Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD)David R Luke, Konrad Tomaszewski, Bharat Damle, et al.
Pageof 36